0.6983
price down icon11.90%   -0.0943
 
loading
전일 마감가:
$0.7926
열려 있는:
$0.7811
하루 거래량:
349.84K
Relative Volume:
1.29
시가총액:
$31.30M
수익:
$19.94M
순이익/손실:
$-37.37M
주가수익비율:
-0.6714
EPS:
-1.04
순현금흐름:
$-33.38M
1주 성능:
-32.20%
1개월 성능:
-40.32%
6개월 성능:
-65.60%
1년 성능:
-88.36%
1일 변동 폭
Value
$0.6951
$0.8201
1주일 범위
Value
$0.6951
$1.02
52주 변동 폭
Value
$0.6951
$6.89

웨어울프 테라 Stock (HOWL) Company Profile

Name
명칭
Werewolf Therapeutics Inc
Name
전화
617-952-0555
Name
주소
200 TALCOTT AVENUE, WATERTOWN
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
HOWL's Discussions on Twitter

HOWL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
HOWL
Werewolf Therapeutics Inc
0.6983 31.30M 19.94M -37.37M -33.38M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

웨어울프 테라 Stock (HOWL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-04-03 개시 JMP Securities Mkt Outperform
2023-08-24 개시 Wedbush Outperform
2023-06-06 재개 Jefferies Buy
2021-09-10 개시 BofA Securities Buy
2021-05-25 개시 Evercore ISI Outperform
2021-05-25 개시 H.C. Wainwright Buy
2021-05-25 개시 Jefferies Buy
2021-05-25 개시 SVB Leerink Outperform
모두보기

웨어울프 테라 주식(HOWL)의 최신 뉴스

pulisher
Apr 03, 2025

Werewolf Therapeutics stock hits 52-week low at $0.85 - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

Werewolf Therapeutics stock hits 52-week low at $0.85 By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Mar 31, 2025

Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Werewolf Therapeutics Reveals Latest Cancer Treatment Progress at Major Healthcare Conference - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Bank of New York Mellon Corp Grows Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Mar 31, 2025
pulisher
Mar 26, 2025

Werewolf Therapeutics stock hits 52-week low at $1.02 By Investing.com - Investing.com Australia

Mar 26, 2025
pulisher
Mar 26, 2025

Werewolf Therapeutics stock hits 52-week low at $1.02 - Investing.com India

Mar 26, 2025
pulisher
Mar 18, 2025

Werewolf Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

HC Wainwright Issues Pessimistic Outlook for HOWL Earnings - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Wedbush Research Analysts Cut Earnings Estimates for HOWL - Defense World

Mar 17, 2025
pulisher
Mar 14, 2025

HC Wainwright Reaffirms Buy Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Reaffirms Outperform Rating for Werewolf Therapeutics (NASDAQ:HOWL) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Werewolf Therapeutics Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Mar 12, 2025
pulisher
Mar 12, 2025

Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Inc. (HOWL) reports earnings - Quartz

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics reports Q4 EPS (46c), consensus (31c) - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides - Bakersfield.com

Mar 11, 2025
pulisher
Mar 11, 2025

HOWLWerewolf Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Mar 11, 2025
pulisher
Mar 04, 2025

Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

What Will Werewolf Therapeutics Reveal at the Leerink Biopharma Conference Next Month? - StockTitan

Mar 04, 2025
pulisher
Mar 01, 2025

Werewolf Therapeutics, Inc. Announces Board Changes and Committee Appointment - Marketscreener.com

Mar 01, 2025
pulisher
Feb 28, 2025

Werewolf Therapeutics (HOWL) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Werewolf Therapeutics stock hits 52-week low at $1.25 By Investing.com - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

Werewolf Therapeutics stock hits 52-week low at $1.25 - Investing.com

Feb 27, 2025
pulisher
Feb 26, 2025

Werewolf Therapeutics Announces Board Resignation and New Appointment - Defense World

Feb 26, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics appoints new board member By Investing.com - Investing.com South Africa

Feb 24, 2025
pulisher
Feb 24, 2025

Werewolf Therapeutics appoints new board member - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Oncology Pioneer Transform Werewolf's Cancer-Fighting Platform? - StockTitan

Feb 24, 2025
pulisher
Feb 11, 2025

Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch - Simply Wall St

Feb 11, 2025
pulisher
Feb 11, 2025

Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Feb 11, 2025
pulisher
Feb 07, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - MarketBeat

Feb 07, 2025
pulisher
Jan 28, 2025

Harmony Biosciences (NASDAQ:HRMY) vs. Werewolf Therapeutics (NASDAQ:HOWL) Head to Head Review - Defense World

Jan 28, 2025
pulisher
Jan 24, 2025

Barclays PLC Increases Stake in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jan 24, 2025
pulisher
Jan 19, 2025

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Up 13.2% in December - MarketBeat

Jan 19, 2025
pulisher
Jan 17, 2025

Jane Street Group LLC Trims Holdings in Werewolf Therapeutics, Inc. (NASDAQ:HOWL) - Defense World

Jan 17, 2025
pulisher
Jan 14, 2025

Werewolf Therapeutics' SWOT analysis: stock faces challenges amid pipeline progress - Investing.com

Jan 14, 2025
pulisher
Jan 14, 2025

Werewolf Therapeutics (NASDAQ:HOWL) Price Target Lowered to $4.00 at JMP Securities - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

JMP Securities Cuts Price Target for Werewolf Therapeutics (NASDAQ:HOWL) to $4.00/Share, Down from $12.00 - HPBL

Jan 14, 2025
pulisher
Jan 14, 2025

Werewolf Therapeutics provides business update, highlights 2025 outlook - Yahoo Finance

Jan 14, 2025
pulisher
Jan 13, 2025

Werewolf Therapeutics Provides Business Update - citybiz

Jan 13, 2025
pulisher
Jan 13, 2025

Werewolf Therapeutics Provides Business Update and Highlights 2025 Strategic Outlook - GlobeNewswire

Jan 13, 2025
pulisher
Jan 13, 2025

Werewolf Therapeutics Unveils Ambitious 2025 Pipeline Plans for Cancer Immunotherapy Programs - StockTitan

Jan 13, 2025

웨어울프 테라 (HOWL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
자본화:     |  볼륨(24시간):